25Jul

EKF Publishes Guide to Good Capillary Blood Sampling

EKF_1

Cardiff, UK – 3rd July 2018 – EKF Diagnostics, the global in vitro diagnostics company, has published an Educational Guide which provides a quick overview of capillary blood sampling best practice. It aims to help health care professionals understand common causes of pre-analytical errors and reduce their impact on hemoglobin results. Entitled ‘Capillary sampling and its relevance for correct hemoglobin results,’ the new Guide is available to download from EKF Diagnostics’ website.

Capillary blood (fingerstick) sampling is increasingly being used worldwide due to the growing availability of point-of-care (POC) testing. With anemia affecting about 25% of the global population and a much higher prevalence in developing countries, hemoglobin is the most frequently performed test in POC hematology. It is also used routinely by blood collection services to ensure safe donations.

Notably, hemoglobin (Hb) values are among the parameters most prone to being affected by pre-analytical errors. Incorrect capillary blood sampling being the most common reason for inaccurate POC hemoglobin results. So, in order to avoid generating variant and misleading Hb results, health care personnel drawing blood must adhere to strict and standardized blood sampling techniques. This ensures accurate and consistent POCT results that are comparable to laboratory techniques.

As well as discussing the reasons behind the vital importance of good capillary blood sampling, the new guide provides easy step-by-step instructions on best practice capillary sampling. These present a simple visual explanation based on published detailed guidelines from the Clinical and Laboratory Standards Institute and the World Health Organization (WHO) with specific considerations added for hemoglobin testing.

EKF’s new capillary sampling guide can be viewed and downloaded at: https://www.ekfdiagnostics.com/capillary-blood-sampling.html.

For full information on the EKF Diagnostics Group, please visit www.ekfdiagnostics.com

Related

Cytox appoints new CCO

Oxford and Manchester, UK – Cytox, a precision medicine company focused on developing solutions to ...

Read More >

HORIBA Medical launches D-Dimer reagent for Yumizen G Haemostasis range

New Yumizen GDDi 2 (D-Dimer) reagent kit for DVT and Pulmonary Embolism diagnosis

Read More >

OGT enhances customer experience with new Cytocell website

Oxford, UK – 7 March 2018. Oxford Gene Technology (OGT), The Molecular Genetics Company, has launch...

Read More >

SpeeDx Pty. Ltd. establishes US-based operation

SYDNEY, AUSTRALIA–(December 04, 2017). SpeeDx Pty. Ltd, a developer of advanced multiplex molecular...

Read More >

QuantuMDx and Molbio announce Memorandum of Understanding (MoU)

QuantuMDx Group Limited and Molbio Diagnostics Private Limited have signed a memorandum of understan...

Read More >

EKF introduces mobile data management solution for the DiaSpect Tm POC hemoglobin analyzer

Cardiff, UK – 13th November 2017 – EKF Diagnostics, the global in vitro diagnostics company, today...

Read More >